Review




Structured Review

Genzyme il-1β immunoreactivity
Il 1β Immunoreactivity, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-1β immunoreactivity/product/Genzyme
Average 90 stars, based on 1 article reviews
il-1β immunoreactivity - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

93
ProSci Incorporated islet il 1β immunoreactivity
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Islet Il 1β Immunoreactivity, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/islet il 1β immunoreactivity/product/ProSci Incorporated
Average 93 stars, based on 1 article reviews
islet il 1β immunoreactivity - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
ProSci Incorporated il 1β immunoreactivity
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Il 1β Immunoreactivity, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 1β immunoreactivity/product/ProSci Incorporated
Average 93 stars, based on 1 article reviews
il 1β immunoreactivity - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Genzyme il-1β immunoreactivity
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Il 1β Immunoreactivity, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-1β immunoreactivity/product/Genzyme
Average 90 stars, based on 1 article reviews
il-1β immunoreactivity - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


IHC for insulin, IL-1β, and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.

Journal: Diabetes Care

Article Title: Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure

doi: 10.2337/dc17-1387

Figure Lengend Snippet: IHC for insulin, IL-1β, and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.

Article Snippet: Islet IL-1β Immunoreactivity Is Seen Even in Very Young Subjects With CF We next analyzed islet IL-1β immunoreactivity (using the ProSci antibody) in the subset of pediatric CF subjects <10 years of age, the currently recommended age to begin screening CF patients for CFRD with oral glucose tolerance tests ( 5 ).

Techniques: Staining, Control, Quantitation Assay

Subject characteristics and islet morphometric analyses in individuals with CF, subdivided according to diabetes and lung transplant status

Journal: Diabetes Care

Article Title: Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure

doi: 10.2337/dc17-1387

Figure Lengend Snippet: Subject characteristics and islet morphometric analyses in individuals with CF, subdivided according to diabetes and lung transplant status

Article Snippet: Islet IL-1β Immunoreactivity Is Seen Even in Very Young Subjects With CF We next analyzed islet IL-1β immunoreactivity (using the ProSci antibody) in the subset of pediatric CF subjects <10 years of age, the currently recommended age to begin screening CF patients for CFRD with oral glucose tolerance tests ( 5 ).

Techniques: